Global lung oncology branch trial 3 (GLOB3): Final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer
E. H. Tan*, J. Rolski, T. Grodzki, C. P. Schneider, U. Gatzemeier, P. Zatloukal, E. Aitini, G. Carteni, H. Riska, Y. H. Tsai, R. Abratt
*此作品的通信作者
- National Cancer Centre
- Maria Sklodowska-Curie Institute of Oncology
- The Regional Hospital for Lung Diseases
- Central Hospital Bad Berka
- Centre of Pneumology and Thoracic Surgery
- Charles University
- Azienda Ospedaliera Carlo Poma
- Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli
- HUS Helsinki University Hospital
- University of Cape Town
研究成果: 期刊稿件 › 文章 › 同行評審
58
引文
斯高帕斯(Scopus)